Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Durect Corp (DRRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 155,520
  • Shares Outstanding, K 162,000
  • Annual Sales, $ 49,170 K
  • Annual Income, $ -3,700 K
  • 36-Month Beta 0.88
  • Price/Sales 3.20
  • Price/Cash Flow N/A
  • Price/Book 5.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.03
  • Number of Estimates 3
  • High Estimate -0.02
  • Low Estimate -0.05
  • Prior Year 0.04
  • Growth Rate Est. (year over year) -175.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.92 +14.13%
on 10/11/18
1.24 -15.32%
on 09/18/18
-0.06 (-5.41%)
since 09/17/18
3-Month
0.92 +14.13%
on 10/11/18
1.66 -36.75%
on 07/30/18
-0.51 (-32.69%)
since 07/17/18
52-Week
0.75 +40.00%
on 10/20/17
2.55 -58.82%
on 04/10/18
-0.76 (-41.99%)
since 10/17/17

Most Recent Stories

More News
DURECT Corporation Appoints Michael H. Arenberg, J.D., M.B.A. as Chief Financial Officer

DURECT Corporation (Nasdaq: DRRX) announced today the appointment of Michael H. Arenberg to the position of Chief Financial Officer, effective October 15, 2018. Mr. Arenberg will be responsible for overseeing...

DRRX : 1.05 (+9.37%)
DURECT to Present at the Cantor Fitzgerald Global Healthcare Conference

DURECT Corporation (Nasdaq: DRRX) announced today that James E. Brown, President and CEO, will be presenting at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, October 3 at 1:40 p.m. Eastern...

DRRX : 1.05 (+9.37%)
DURECT Announces Methydur Sustained Release Capsules Receive Marketing Authorization for ADHD in Taiwan

DURECT Corporation (Nasdaq: DRRX) today announced that Orient Pharma Co., Ltd., its licensee for certain Asian and South Pacific countries, has informed DURECT that it has obtained marketing authorization...

DRRX : 1.05 (+9.37%)
DURECT to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

DURECT Corporation (Nasdaq: DRRX) announced today that James E. Brown, President and CEO, will be presenting at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright...

DRRX : 1.05 (+9.37%)
Recent Analysis Shows DURECT, Corporacion America Airports S.A., Golden Star Resources, MacroGenics, Merus N.V., and Superior Uniform Group Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of DURECT Corporation (NASDAQ:DRRX),...

MGNX : 19.63 (+0.72%)
CAAP : 8.24 (-0.36%)
DRRX : 1.05 (+9.37%)
GSS : 0.73 (unch)
MRUS : 16.90 (+3.11%)
GLNS : 1.1100 (unch)
SGC : 18.37 (-2.03%)
Data Projects the NASH Market Will Eclipse USD 21 Billion by 2025

According to a report published by Allied Market Research, the global non-alcoholic steatohepatitis (NASH) market was valued at USD 1,179 Million in 2017 and is expected to reach USD 21,478 Million by...

BTHCF : 0.0800 (-8.05%)
CNAT : 5.16 (-0.77%)
BTH.CN : 0.225 (+114.29%)
GALT : 4.99 (-2.54%)
DRRX : 1.05 (+9.37%)
GLMD : 12.25 (+2.51%)
Durect: 2Q Earnings Snapshot

CUPERTINO, Calif. (AP) _ Durect Corp. (DRRX) on Wednesday reported a loss of $7 million in its second quarter.

DRRX : 1.05 (+9.37%)
DURECT Corporation Announces Second Quarter 2018 Financial Results and Provides Corporate Update

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2018 and provided a corporate update.

DRRX : 1.05 (+9.37%)
DURECT Corporation, Near Term PDUFA Dates, Pipeline Review and Analysts Target

NEW YORK, NY / ACCESSWIRE / July 23, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive...

DRRX : 1.05 (+9.37%)
NVS : 85.28 (-0.51%)
Complimentary Technical Snapshots on Teva Pharma Industries and Three More Drug Makers Stocks

Stock Research Monitor: DEPO, DRRX, and ENDP

DRRX : 1.05 (+9.37%)
TEVA : 21.19 (-4.81%)
DEPO : 7.30 (+1.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade DRRX with:

Business Summary

Durect Corp. is pioneering the treatment of chronic diseases and conditions by developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. Its pharmaceutical systems combine engineering innovations and delivery technology from...

See More

Key Turning Points

2nd Resistance Point 1.17
1st Resistance Point 1.11
Last Price 1.05
1st Support Level 0.96
2nd Support Level 0.87

See More

52-Week High 2.55
Fibonacci 61.8% 1.86
Fibonacci 50% 1.65
Fibonacci 38.2% 1.44
Last Price 1.05
52-Week Low 0.75

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar